IRIS
CICONE, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.976
AS - Asia 1.667
EU - Europa 586
SA - Sud America 540
Continente sconosciuto - Info sul continente non disponibili 333
AF - Africa 37
OC - Oceania 7
Totale 5.146
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.893
SG - Singapore 752
BR - Brasile 417
CN - Cina 308
IT - Italia 237
VN - Vietnam 234
IN - India 121
GB - Regno Unito 67
BD - Bangladesh 60
HK - Hong Kong 57
AR - Argentina 53
CA - Canada 49
SE - Svezia 48
ID - Indonesia 43
NL - Olanda 37
FR - Francia 34
DE - Germania 30
EC - Ecuador 25
MX - Messico 25
EE - Estonia 21
RO - Romania 20
ZA - Sudafrica 18
CO - Colombia 16
CZ - Repubblica Ceca 14
GR - Grecia 13
JP - Giappone 12
RU - Federazione Russa 12
FI - Finlandia 11
PY - Paraguay 11
IR - Iran 9
CL - Cile 8
PH - Filippine 7
UZ - Uzbekistan 7
AU - Australia 6
CH - Svizzera 6
IQ - Iraq 6
LV - Lettonia 6
MY - Malesia 6
TR - Turchia 6
PE - Perù 5
UA - Ucraina 5
IL - Israele 4
KE - Kenya 4
KR - Corea 4
PT - Portogallo 4
TN - Tunisia 4
TW - Taiwan 4
UY - Uruguay 4
AT - Austria 3
ES - Italia 3
EU - Europa 3
IE - Irlanda 3
JM - Giamaica 3
JO - Giordania 3
KZ - Kazakistan 3
PK - Pakistan 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AZ - Azerbaigian 2
BE - Belgio 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EG - Egitto 2
GH - Ghana 2
MA - Marocco 2
NP - Nepal 2
PL - Polonia 2
SA - Arabia Saudita 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BG - Bulgaria 1
BH - Bahrain 1
DK - Danimarca 1
ET - Etiopia 1
FJ - Figi 1
GW - Guinea-Bissau 1
HN - Honduras 1
HR - Croazia 1
LB - Libano 1
LT - Lituania 1
LY - Libia 1
MM - Myanmar 1
MN - Mongolia 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PR - Porto Rico 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.817
Salva come PNG Salva come JPEG
Città #
San Jose 352
Singapore 285
Chandler 181
Ashburn 175
Dallas 127
Santa Clara 122
Bengaluru 99
Hefei 99
Ho Chi Minh City 94
Council Bluffs 89
Princeton 70
Lawrence 69
Milan 69
Hong Kong 56
Beijing 53
Wilmington 46
London 41
Hanoi 40
Los Angeles 38
Chicago 36
São Paulo 31
Ottawa 25
Rome 25
Jakarta 19
Boardman 17
Des Moines 17
The Dalles 14
Haiphong 13
New York 12
Belo Horizonte 11
Guayaquil 11
Rio de Janeiro 11
Timisoara 11
Mexico City 10
Nijmegen 10
West Jordan 10
Columbus 9
Da Nang 9
Johannesburg 9
Munich 9
Norwalk 9
Bayonne 8
Chennai 8
Naples 8
Redmond 8
Toronto 8
Boston 7
Campinas 7
Charlotte 7
Guarulhos 7
Horia 7
San Francisco 7
Shanghai 7
Stockholm 7
Brasília 6
Dhaka 6
Hanover 6
Helsinki 6
Lanskroun 6
Manchester 6
Ninh Bình 6
Olomouc 6
Redwood City 6
Riga 6
Santo André 6
Tashkent 6
Amsterdam 5
Asunción 5
Atlanta 5
Biên Hòa 5
Buenos Aires 5
Guangzhou 5
Kuala Selangor 5
Massy 5
Phoenix 5
Poplar 5
Porto Alegre 5
Quito 5
Recife 5
Tokyo 5
Turku 5
Ankara 4
Ann Arbor 4
Assago 4
Bogotá 4
Bologna 4
Brooklyn 4
Bắc Giang 4
Can Tho 4
Caxias do Sul 4
Fortaleza 4
Hamilton 4
Isfahan 4
L'aquila 4
Manila 4
Nairobi 4
New Delhi 4
Oosterbeek 4
Paola 4
Pereira 4
Totale 2.752
Salva come PNG Salva come JPEG
Nome #
Peptide receptor radionuclide therapy with somatostatin analogs beyond gastroenteropancreatic neuroendocrine tumors 108
In-111-PCTA-VRC07 a Radiolabeled Broadly Neutralizing Antibody For HIV Imaging in Mice 101
EANM guidance document: dosimetry for first-in-human studies and early phase clinical trials 94
F-DOPA PET identifies high tumor grade and anaplastic transformation in non-enhancing gliomas 90
Volumetric assessment of gliomas: Comparison between F-18-FET and Ga-68-NODAGA-RGDyK 90
A Monte Carlo model for the internal dosimetry of choroid plexuses in nuclear medicine procedures 88
Correction to: Preclinical Evaluation and Dosimetry of [111In] CHX-DTPA-scFv78-Fc Targeting Endosialin/Tumor Endothelial Marker 1 (TEM1) (Molecular Imaging and Biology, (2020), 22, 4, (979-991), 10.1007/s11307-020-01479-8) 85
Anatomical substrates of cognitive and clinical dimensions in first episode schizophrenia 84
A theoretical dose-escalation study based on biological effective dose in radioimmunotherapy with 90Y-ibritumomab tiuxetan (Zevalin) 83
Impact of chemotherapy with Temozolomide on physiological brain 18F-DOPA uptake in patients with glioma 81
Amino acid PET and MR perfusion imaging in brain tumours 81
Preclinical evaluation of a single-chain variable anti TEM-1 fragment labeled with In-111 and Tb-152 78
"Boom-Boom" radioimmunotherapy of lymphomas: Are two magic bullets better than one? 76
Accuracy of F-DOPA PET and perfusion-MRI for differentiating radionecrotic from progressive brain metastases after radiosurgery 74
18 F-DOPA uptake does not correlate with IDH mutation status and 1p/19q co-deletion in glioma 71
Cardiac radionuclide imaging in rodents: A review of methods, results, and factors at play 71
Unespected dectection of unruptured brain arteriovenous malformation with 18F-DOPA PET/MR 67
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standard for PET imaging of brain metastases: version 1.0 67
Do we need dosimetry for the optimization of theranostics in CNS tumors? 66
Value of F-DOPA PET in the long term follow up of radionecrotic brain metastases after radiosurgery: comparison with MRI 65
18F-DOPA Positron Emission Tomography in Medulloblastoma: 2 Case Reports 64
Advanced imaging techniques for radiotherapy planning of gliomas 63
Thyro-entero-gastric autoimmunity: Pathophysiology and implications for patient management 59
Dosimetric Approaches for Radioimmunotherapy of Non-Hodgkin Lymphoma in Myeloablative Setting 59
18F-PSMA-1007 salivary gland dosimetry: comparison between different methods for dose calculation and assessment of inter- and intra-patient variability 59
EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands 58
Cross-sectional evaluation of FGD-avid polyostotic fibrous dysplasia: MRI, CT and PET/MRI findings 58
First in-human radiation dosimetry of the gastrin-releasing peptide (GRP) receptor antagonist 68 Ga-NODAGA-MJ9 57
18F-DOpA uptake parameters in glioma: Effects of patients’ characteristics and prior treatment history 57
Impaired insulin-stimulated myocardial glucose metabolic rate is associated with reduced estimated myocardial energetic efficiency in subjects with different degrees of glucose tolerance 56
Effects of 26 weeks of treatment with empagliflozin versus glimepiride on the myocardial glucose metabolic rate in patients with type 2 diabetes: The randomized, open-label, crossover, active-comparator FIORE trial 56
Comparison of absorbed dose extrapolation methods for mouse-to-human translation of radiolabelled macromolecules 56
Central nervous system- Primary and secondary Tumours: Radiolabelled Amino Acids 55
Long-term metabolic evolution of brain metastases with suspected radiation necrosis following stereotactic radiosurgery: longitudinal assessment by F-DOPA PET 55
The contest between internal and external-beam dosimetry: The Zeno's paradox of Achilles and the tortoise 55
Central nervous system - Primary tumours 54
Three-dimensional patient-specific dosimetry in radioimmunotherapy with 90Y-ibritumomab-tiuxetan 54
Editorial: Perspectives in Small Animal Radionuclide Imaging 53
Repeated stereotactic radiosurgery for patients with progressive brain metastases 53
LONG TERM FOLLOW UP OF RADIONECROTIC BRAIN METASTASES ASSESSED BY SERIAL F-DOPA PET/CT SCANS 52
Preclinical Evaluation and Dosimetry of [111In]CHX-DTPA-scFv78-Fc Targeting Endosialin/Tumor Endothelial Marker 1 (TEM1) 52
Editorial: Nuclear Medicine in the Context of Personalized Medicine 52
Hyperhomocysteinemia in acute iatrogenic hypothyroidism: the relevance of thyroid autoimmunity 52
Quantification of dose nonuniformities by voxel-based dosimetry in patients receiving 90Y-ibritumomab-tiuxetan 52
Single-fraction versus multifraction (3 × 9 gy) stereotactic radiosurgery for large (>2 cm) brain metastases: A comparative analysis of local control and risk of radiation-induced brain necrosis 52
Immune-related [18F]FDG PET findings in patients undergoing checkpoint inhibitors treatment: correlation with clinical adverse events and prognostic implications 51
ROLE OF 18F-DOPA PET/CT IN NON-ENHANCING GLIOMAS 51
Elevated whole blood viscosity is associated with an impaired insulin-stimulated myocardial glucose metabolism 51
Volumetric assessment of recurrent or progressive gliomas: comparison between F-DOPA PET and perfusion-weighted MRI 50
Reply to: "assessment of imaging biomarkers in the follow-up of brain metastases after SRS" 50
Erratum to: Amino acid PET and MR perfusion imaging in brain tumours (Clinical and Translational Imaging, (2017), 5, 3, (209-223), 10.1007/s40336-017-0225-z) 49
Internal radiation dosimetry of a 152Tb-labeled antibody in tumor-bearing mice 49
In Reply to the Letter to the Editor Regarding “18F-DOPA PET in Medulloblastoma: Two Case Reports” 49
Not all that glitters is COVID! Differential diagnosis of FDG-avid interstitial lung disease in low-prevalence regions 48
Multiparametric evaluation of low grade gliomas at followup: Comparison between diffusion and perfusion MR with 18F-FDOPA PET 47
PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group 46
Tc-99m DTPA cisternography shows disappearance of cerebrospinal fluid leakage after standing a short time 46
Comment on hatzoglou et al: Dynamic contrastenhanced MRI perfusion versus 18FDG PET/CT in differentiating brain tumor progression from radiation injury 46
Follicular lymphoma at relapse after rituximab containing regimens: Comparison of time to event intervals prior to and after 90Y-ibritumomab-tiuxetan 46
Dosimetry of nuclear medicine therapies: current controversies and impact on treatment optimization 45
Dosimetry-based treatment planning for molecular radiotherapy: A summary of the 2017 report from the Internal Dosimetry Task Force 44
Outcomes of postoperative stereotactic radiosurgery to the resection cavity versus stereotactic radiosurgery alone for melanoma brain metastases 44
The importance of standardizing acquisition settings and interpretation criteria of radionuclide cisternography 44
Fatal pulmonary tumour thrombotic microangiopathy: do typical FDG-PET findings exist? 43
Monte Carlo 90Y PET/CT dosimetry of unexpected focal radiation-induced lung damage after hepatic radioembolisation 43
Radioimmunotherapy of heavily pre-treated, non-Hodgkin's lymphoma patients: efficacy and safety in a routine setting 43
Why not consider PET/CT in the workup of pulmonary tumour thrombotic microangiopathy? 43
Repeated amino acid PET imaging for longitudinal monitoring of brain tumors 42
Erratum: Tc-99m DTPA cisternography shows disappearance of cerebrospinal fluid leakage after standing a short time (Clinical Nuclear Medicine (2009)(29-30)) 42
Metabolic Evolution of Brain Metastasis after Stereotactic Radiosurgery: Mismatch between F-DOPA and FDG PET 42
LONGITUDINAL HYBRID PET/MRI IN JUVENILE-ONSET HUNTINGTON DISEASE (JOHD) 41
Functional connectivity of the cortico-subcortical sensorimotor loop is modulated by the severity of nigrostriatal dopaminergic denervation in Parkinson's Disease 41
Fundamentals of internal radiation dosimetry 40
Radioimmunotherapy of Non-Hodgkin B-cell Lymphoma: An update 40
First in-human radiation dosimetry of 68Ga-NODAGA-RGDyK 40
THE RELATIONSHIP BETWEEN BRAIN STRUCTURE AND GLUCOSE METABOLISM VARIES OVER TIME IN JUVENILE-ONSET HUNTINGTON DISEASE 39
EANM enabling guide: how to improve the accessibility of clinical dosimetry 39
Thyro-gastric autoimmunity in patients with differentiated thyroid cancer: a prospective study 39
Metabolic Syndrome Is Associated With Impaired Insulin-Stimulated Myocardial Glucose Metabolic Rate in Individuals With Type 2 Diabetes: A Cardiac Dynamic 18F-FDG-PET Study 38
Translating the theranostic concept to neuro-oncology: disrupting barriers 37
Variations in the practice of molecular radiotherapy and implementation of dosimetry: results from a European survey 37
Leptomeningeal disease and brain control after postoperative stereotactic radiosurgery with or without immunotherapy for resected brain metastases 37
Studying the metabolic activity of red bone marrow by means of FDG-PET: The need for a standardization 36
Results from an EANM survey on time estimates and personnel responsible for main tasks in molecular radiotherapy dosimetry 35
Pediatric Huntington Disease Brains Have Distinct Morphologic and Metabolic Traits: the RAREST‐JHD Study 33
LONGITUDINAL BRAIN VOLUME AND GLUCOSE METABOLISM CHANGES IN PATIENTS WITH JUVENILE-ONSET HUNTINGTON DISEASE 33
Rituximab-like radiolabelled antibodies for the treatment of non-hodgkin's lymphomas 33
Malignant Lymphoma in Children 33
Sex-specific differences in myocardial glucose metabolic rate in non-diabetic, pre-diabetic and type 2 diabetic subjects 32
Imaging the future: A report from the Young Daily EANM Forum 2013 31
Renal Cell Carcinoma: the Oncologist Asks, Can PSMA PET/CT Answer? 30
Reply to Zaragori et al.: “Is IDH mutation status associated with 18F-FDopa PET uptake” 29
Expression of large neutral amino acid transporters LAT1 and LAT2 in medulloblastoma 29
Prognostic value of FDG uptake by the bone marrow in squamous cell carcinoma of the head and neck 28
FET and FDOPA PET Imaging in Glioma 27
The mean striatal 18 F-DOPA uptake is not a reliable cut-off threshold for biological tumour volume definition of glioma 27
Visual and quantitative approach to bone marrow foci of increased glucose uptake on PET/CT in a case of aplastic anaemia 26
Functional connectivity of the cortico-subcortical sensorimotor loop is modulated by the severity of nigrostriatal dopaminergic denervation in Parkinson’s Disease 25
Editorial: "Nuclear medicine in cancer diagnosis" 24
Totale 5.146
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.105
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.105
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022365 0 2 7 161 20 2 6 52 21 49 22 23
2022/2023523 152 44 7 46 50 32 10 35 65 33 35 14
2023/2024322 58 27 25 25 17 54 12 21 11 29 31 12
2024/2025898 125 15 18 27 81 122 29 30 140 47 108 156
2025/20262.672 103 300 364 631 261 70 213 163 280 139 96 52
2026/2027154 27 127 0 0 0 0 0 0 0 0 0 0
Totale 5.146